Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollán1,2, Beatriz Pérez-Gómez1,2, Roberto Pastor-Barriuso1,2, Jesús Oteo3,4, Miguel A Hernán5,6,7, Mayte Pérez-Olmeda3, Jose L Sanmartín8, Aurora Fernández-García2,9, Israel Cruz10, Nerea Fernández de Larrea1,2, Marta Molina11, Francisco Rodríguez-Cabrera10, Mariano Martín8, Paloma Merino-Amador9, Jose León Paniagua12, Juan F Muñoz-Montalvo8, Faustino Blanco11, Raquel Yotti13
1National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain
2Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain
3National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain
4Spanish Network for Research in Infectious Diseases (REIPI), Institute of Health Carlos III, Madrid, Spain
5Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
6Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
7Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA
8Deputy Directorate of Information Technologies, Ministry of Health, Madrid, Spain
9Department of Clinical Microbiology, Hospital Clínico San Carlos, Madrid, Spain
10National School of Public Health, Institute of Health Carlos III, Madrid, Spain
11General Secretary of Health, Ministry of Health, Madrid, Spain
12General Secretariat, Institute of Health Carlos III, Madrid, Spain
13Directorate, Institute of Health Carlos III, Madrid, Spain